The board of Sinopharm Group Co. Ltd. announced that on 12 January 2018, due to work adjustment, Mr. Lian Wanyong tendered his resignation from the position as a non-executive Director and a member of the Audit Committee with immediate effect, and Mr. Li Dongjiu tendered his resignation from the position as a non-executive Director, a member of the Audit Committee, a member of the Remuneration Committee and a member of the Strategy and Investment Committee with immediate effect. On the same day, the Board resolved to propose to appoint Ms. Rong Yan as a non-executive Director and a member of the Audit Committee, and propose to appoint Mr. Wu Yijian as a non-executive Director, a member of the Audit Committee, a member of the Remuneration Committee and a member of the Strategy and Investment Committee. In accordance with the Articles of Association, the proposed appointments of Ms. Rong Yan and Mr. Wu Yijian as non-executive Directors are subject to the approval by the Shareholders at the EGM. The terms of office of Ms. Rong Yan and Mr. Wu Yijian as non-executive Directors will take effect from the date of approval by the Shareholders at the EGM and until the of the term of the current session of the Board. Both of Ms. Rong Yan and Mr. Wu Yijian's positions as a member of the respective committees under the Board will take effect upon the approval of their appointments as non-executive Directors by the Shareholders at the EGM. On 12 January 2018, Mr. Yang Jun tendered his resignation from the position as an Employee Representative Supervisor with immediate effect due to work adjustment. On the same day, Mr. Zhang Hongyu was elected as an Employee Representative Supervisor at the meeting of the employee representatives of the Company with immediate effect. Ms. Rong Yan, aged 49, having over 26 years' working experience, is currently the director of Finance Department of China National Pharmaceutical Group Corporation. Mr. Wu Yijian, aged 48, is currently the president assistant and the director of the commercial pharmaceutical management committee of Shanghai Fosun Pharmaceutical Group Co. Ltd., and the chairman of the supervisory committee of China National Accord Medicines Corporation Ltd.